News
BCTX
3.450
0.00%
0.000
Weekly Report: what happened at BCTX last week (0803-0807)?
Weekly Report · 2d ago
BriaCell Therapeutics Receives FDA Clearance To Proceed With Clinical Evaluation Of Bria-PROS+, Its Next-Gen Personalized Off-The-Shelf Immunotherapy For Prostate Cancer
Benzinga · 08/05 11:33
BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer
Barchart · 08/05 06:30
Weekly Report: what happened at BCTX last week (0727-0731)?
Weekly Report · 08/03 09:06
Weekly Report: what happened at BCTX last week (0720-0724)?
Weekly Report · 07/27 09:07
Weekly Report: what happened at BCTX last week (0713-0717)?
Weekly Report · 07/20 09:06
Source Rock Royalties Declares Monthly Dividend and Grants New RSUs
TipRanks · 07/16 11:51
BriaCell announces Odette Cancer Centre joins Bria-IMT trial
TipRanks · 07/16 11:40
Odette Cancer Centre At Sunnybrook Health Sciences Centre Joined BriaCell’s Ongoing Pivotal Phase 3 Study Of Bria-IMT Plus Immune Checkpoint Inhibitor In Metastatic Breast Cancer
Benzinga · 07/16 11:36
Stocks in play: BriaCell Therapeutics Corp.
Barchart · 07/16 08:53
BriaCell Therapeutics Enters Manufacturing Arrangement With FUJIFILM Biotechnologies To Support Phase 3 Clinical Development And Potential Future Commercial Supply Of Its Allogenic Cell Therapy BRIA-IMT
Benzinga · 07/15 11:35
BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™
Barchart · 07/15 06:30
Weekly Report: what happened at BCTX last week (0706-0710)?
Weekly Report · 07/13 09:07
BriaCell Therapeutics Engages Charles River Associates, Kaleio To Explore Commercial Strategy, Market Access Evaluation Of Bria-IMT
Benzinga · 07/07 11:32
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™
Barchart · 07/07 06:30
Weekly Report: what happened at BCTX last week (0629-0703)?
Weekly Report · 07/06 09:07
Weekly Report: what happened at BCTX last week (0622-0626)?
Weekly Report · 06/29 09:06
BriaCell Subsidiary Highlights Interim Results, Ongoing Losses
TipRanks · 06/26 20:33
BriaCell Partners With Uneedle To Support Scalable Microneedle Delivery Of Bria-IMT
NASDAQ · 06/26 10:06
BriaCell enters MoU with Uneedle for microneedle technology
TipRanks · 06/25 11:45
More
Webull provides a variety of real-time BCTX stock news. You can receive the latest news about Briacell Therapeutics Corp through multiple platforms. This information may help you make smarter investment decisions.
About BCTX
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.